The single site for N-linked glycosylation of the /?-subunit of bovine LH (LH/3) was disrupted by oligonucleotide-directed mutagenesis to assess its potential roles in the biosynthesis, transport, and hormonal activity of the LH «//? heterodimer. Pulsechase studies performed with stably transfected Chinese hamster ovary cells that expressed both «-subunit (fully glycosylated) and nonglycosylated LH/3 revealed that turnover, transport, and secretion of newly synthesized, nonglycosylated LH/3 were effectively blocked over a 22-h span. Free nonglycosylated LH0, like free wild-type LH/?, was sequestered inside the cell; therefore, the intracellular retention of uncombined LH/?-subunit is not due to a signal located within the N-glycan moiety. Nevertheless, an older pool of unlabeled, nonglycosylated LH/3-subunit was available for combination with newly synthesized a-subunit, as verified by immunoprecipitation of radiolabeled a-subunit from cell lysates and culture medium with anti-LH/3-antiserum. This heterodimer displayed normal kinetics of secretion (t 1/2 = 2.4 h) as compared to fully glycosylated LH (tv2 = 2.1 h). The wild-type and mutant forms of LH were also purified from culture supernatants of the two cell lines, and were compared for their relative abilities to stimulate progesterone secretion in cultured rat Leydig cells. Both proteins displayed similar potency (ED 50 = 32 vs. 41 ng/ml, respectively) and maximal stimulation of progesterone release (Pmax = 2.7 vs. 2.5 M9/ml), indicating that N-linked glycosylation of the LHjS-subunit does not play a significant role in LH signal transduction. Collectively, these results indicate that N-linked glyco-
INTRODUCTION
The glycoprotein hormone family consists of three products of the anterior pituitary, commonly known as LH, FSH, and TSH, as well as the placental hormone of primates and horses, CG. These glycoproteins are related heterodimers containing a common a-subunit and one of four unique /3-subunits which confer specific hormonal function (1, 2) . Collectively, the glycoprotein hormones have diverse N-and O-linked glycosylation patterns which are unique not only for each subunit, but can vary in the same subunit across species. The a-subunit possesses two AMinked oligosaccharide attachment sites, while the different /3-subunits contain either one or two sites (1) (2) (3) (4) . In addition, free a-subunit is secreted with a unique O-linked glycan, a modification which apparently prevents subsequent assembly with /3-subunit (5) .
Considerable effort has been directed toward understanding the molecular mechanisms underlying assembly, secretion, and biological activity of these hormones. The bulk of the current evidence suggests that combination of the glycoprotein hormone a-and /3-subunits occurs in the endoplasmic reticulum (ER) before high mannose W-glycans are processed to their mature forms (6) . While newly synthesized a-subunit combines with newly synthesized CG/3, TSH/3, and probably FSHjS (7) (8) (9) , LH/3-subunit displays a lag period after its syn-thesis during which it appears to be incapable of combination with a-subunit. Instead, newly synthesized asubunit combines with a pool of previously synthesized LHj8(1O, 11).
Site-specific roles have been identified by site-directed mutagenesis for the A/-glycosylation of human a-and CGjS-subunits in the assembly, secretion, and biological activity of human CG (hCG) (12) (13) (14) . Furthermore, by examining the biological activities of LH and FSH assembled in vitro from various combinations of native and chemically deglycosylated a-and /3-subunits, Sairam and Bhargavi (15) have demonstrated the importance of the A/-linked carbohydrates of the a-subunit for induction of adenylate cyclase upon binding to target cell receptors. In contrast, deglycosylated /?-subunits retained normal properties of assembly and biological activity. No studies to date, however, have determined the potential significance of site-specific glycosylation of LH or the remaining glycoprotein hormones, TSH and FSH, for assembly, secretion, or signal transduction.
In this paper, we have addressed whether the single A/-glycan of the bovine LH/3 (bl_H/3)-subunit affects the assembly, secretion, and hormonal properties of LH. Our studies indicate that the single A/-glycan of LH/3 plays a major role in the intracellular stability of the free subunit, but otherwise does not alter its kinetics of assembly, nor its kinetics of secretion as a heterodimer with a-subunit. In addition, prevention of A/-glycosylation of the bLHjS-subunit does not alter the biological activity of the resulting secreted heterodimer, suggesting that the /V-glycan of the bLH/3-subunit does not play a significant role in signal transduction.
RESULTS

Transfection and Isolation of Chinese Hamster Ovary Cells which Express LH Genes Encoding either a Glycosylated or Nonglycosylated £-Subunit
The tripeptide signal for AMinked glycosylation in the LH/3-subunit (N 13 -A 14 -T 15 ) was disrupted by site-directed mutagenesis, employing the conservative substitution of threonine 15 with an isoleucine residue (Fig. 1 A) . This substitution should have little or no effect on the overall subunit structure, as an isoleucine residue is found at the same relative position of the human LH/? (hLH/3)-subunit. Structural genes encoding the LH/3-subunit with either an intact or modified A/-glycosylation signal were placed under transcriptional control of the Rous sarcoma virus 3'-long terminal repeat (LTR) promoter/ enhancer and stably transfected into a CHO cell line (MTXa) secreting wild-type bovine a-subunit [ Fig. 1  (10) ]. This approach enabled us to study the role played by the single oligosaccharide moiety of the /3-subunit in assembly, transport, and hormonal activity of the a/(3 heterodimer.
Polybrene transfection of the MTXa cell line with expression vectors encoding wild-type or mutant LH/3- 15 with an isoleucine residue, as found in the hLH/3-subunit. The one-letter symbols for the amino acids are: A, alanine; N, asparagine; I, isoleucine; F, phenylalanine; P, proline; S, serine; T, threonine; and V, valine. Amino acid residues which are normally glycosylated have been identified with an asterisk. B, Construction of expression vectors encoding wild type and mutant LH/3-subunit. Site-directed mutagenesis was accomplished by the protocol of Zoller and Smith (24) , using a single stranded DNA template generated in M13 that included the 1.8 kb genomic Pst\ (Pst\ = P) fragment of the bLH/3 gene represented above. Solid blocks are amino acid coding regions, hatched blocks are untranslated regions of exons, and clear blocks are introns and flanking 3'-DNA. The fragments encoding either wild type or mutant LH/3-subunit were inserted into the vector pRSVCAT (31) under the transcriptional control of the LTR of the Rous sarcoma virus (RSV LTR), yielding the vectors pRSVbLHjS*" and pRSVbLH/r ut . The bacterial gene encoding chloramphenicol acetyltransferase (CAT) remained in the final constructs, but was rendered nugatory by the LH/3-gene insertion. Also shown are the nucleotide (nt) and amino acid (aa) coding sequences present within the wild type and mutated AMinked glycosylation signals of the bovine LH# subunit. subunits ( Fig. 1) , along with a plasmid conferring neomycin resistance, yielded a large number of stable drugresistant clones (~100 clones per transfection). These were screened for expression and secretion of LH/3-subunit through the use of an enzyme-linked immunosorbent assay (ELISA) which detected both free and combined forms of the protein (see Materials and Methods) . Approximately 50% of the stable clones expressed immunoreactive LHjS-subunit.
Northern blot analysis further revealed expression of a-and /3-subunit mRNAs of the expected sizes in the screened cell lines [data not shown (10, 16) ]. One clone from each transfection was selected for further com-parative study on the basis of their match in a-and 0-subunit mRNA expression; these clones were designated WT and MUT in reference to the respective wildtype or mutant LHj8-genes expressed. The WT cells expressed a 5-fold higher level of a-subunit mRNA and 2-fold lower level of LH/3-subunit mRNA than the MUT cell; the ratio of a to LH/3-mRNA was approximately 3:1 in WT cells and 1:2 in MUT cells.
Pulse-Chase Analysis of LH Subunit Expression in WT and MUT Cells
Relative rates of heterodimer assembly and secretion of the wild-type and mutant LH/3-subunits were assessed in the WT and MUT clones by pulse-chase analysis, using a 10-min pulse of [ 35 S]methionine and increasing times of chase with excess unlabeled methionine. Radiolabeled LH subunits were visualized by subjecting cell lysates and culture supernatants to quantitative immunoprecipitation with antisera directed against either the a-or LH/3-subunit, followed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and autoradiography. These antisera are reactive with both their respective free and dimer-associated subunits (16) , making it possible to study the turnover and secretion of both forms of the a-and LH/3-subunits. For example, LH/3-antibodies will precipitate both the free and combined forms of LH/3. As immunoprecipitated LH heterodimers are denatured before SDS-PAGE, the radiolabeled LH/3-subunit band represents the total amount of LHj8-subunit present. Appearance of radiolabeled a-subunit in an LH/3-antibody immunoprecipitate occurs by virtue of the avid noncovalent association between the a-and LH/3-subunits. Thus, LH/3-antibody immunoprecipitates provide a measure of the newly synthesized total LHjS-subunit and dimer a-subunit in a given sample. Conversely, the aantiserum precipitates free and combined a-subunit, as well as the dimeric form of LHj8, to provide an index of the combination of newly synthesized LH/3-subunit with a-subunit.
The LH subunits expressed in the CHO cell system displayed diverse molecular weight forms. Posttranslational processing of the a-subunit, probably representing alterations in carbohydrate structure, was apparent over the course of the chase in both WT and MUT cells, starting from an early 20.5 kilodalton (kDa) intracellular form to 19.5 kDa in the first 1 h after the pulse (Fig. 2,  A-D) . The secreted form of the protein was observed to be a doublet of approximately 20 kDa (Fig. 2, A-D) for both total and dimeric a-subunit. Both the intracellular and secreted forms of WT LH/3 were detected as a band of approximately 18 kDa, while the intracellular and secreted forms of the mutant nonglycosylated LH/3-subunit (NG-bLH/3) was approximately 14 kDa. The latter was consistent with the expected size of nonglycosylated LH/3-subunit.
Several points can be drawn from the pulse-chase analysis of WT cells regarding LH synthesis, secretion, and turnover. Newly synthesized a-subunit combines almost immediately with available LH/3-subunit, as shown by the appearance of radiolabeled a-subunit in the anti-LH/3-immunoprecipitates of cell lysates as early as the 10-min pulse period, before the initiation of the chase (Fig. 2C ). Approximately 50% of the total asubunit is present as a dimer form throughout the chase period, as determined by comparison of the a-subunit precipitated by anti-a (total a) and anti-LH/3 (dimer a) antibodies (Figs. 2 and 3 ). In addition, approximately 50% of the newly synthesized a-subunit is eventually secreted into the medium; the subunit is equally partitioned between free and dimer forms, indicating that intracellular turnover involves both forms of a-subunit.
Virtually no radioactive LH/3 subunit appears in the heterodimer during the first 1.5 h after the radioactive pulse. This is consistent with our earlier data (10) and other reports (8, 11) , indicating that newly synthesized a-subunit combines rapidly with a pool of previously synthesized (unlabeled) LH/3-subunit. Radiolabeled asubunit immunoprecipitated with LHjS-antibodies in- subunit. • , total lysate LH/3-subunit; • -• , total secreted LHj8-subunit; A A, dimer LH/3-subunit. These data represent the average of two separate pulse-chase experiments, including the gels displayed in Fig. 2 . Relative densitometric units were derived for both experiments using total lysate a-subunit as an arbitrary standard of 100 U.
deed represents dimeric a-subunit, as demonstrated by immunoprecipitations which were performed in the presence of excess nonradiolabeled a-and LH/3-subunit competitors. Unlabeled LH/3, but not a-subunit, completely displaced with a-subunit from LH/3-antibody immunoprecipitates, indicating that the a-subunit had been precipitated via its noncovalent association with the LH/3-subunit and was not the result of contaminating a-subunit antibodies (data not shown). Less prominent radioactive bands of smaller apparent molecular weight which are precipitated from WT cell lysates with asubunit antibodies during the early pulse and chase time points are derived from the a-subunit rather than the LHj8-subunit, as their sizes are not consistent with the expected molecular weight of LH/3-subunit. Furthermore, the same profile of labeled proteins is also observed in the MUT cell line, where the observed electrophoretic mobility of the nonglycosylated LH/3-subunit is clearly distinct from these species (Fig. 2C) .
The secretion of heterodimer molecules containing newly synthesized (radiolabeled) LH/3 is delayed relative to heterodimer containing newly synthesized a-subunit (Figs. 2, A and C, and 3; Table 1 ). This can be explained by the existence of assembly-incompetent and assembly-competent pools of LH/3-subunit within the cell, and implies that LH/3 requires a time-dependent conversion from the former pool into the latter. In addition, free LH/3 is retained in the cell rather than secreted, consistent with earlier observations (8, 10, 11) . Thus, secretion of LH/3 occurs only if it is rescued via combination with a-subunit.
Pulse-chase analysis conducted in MUT cells, which expressed NG-bLH/3, revealed some important differences in LH synthesis and secretion relative to that seen in WT cells. First, the LH/3-immunoprecipitations indicated a difference in the apparent size of the LH/3-subunit (14 kDa in the MUT cells vs. 18 kDa in WT cells; Fig. 2 , A, C, D), consistent with a lack of A/-glycan that resulted from site-directed modification of the consensus A/-linked glycosylation signal (Ref. 17 ; Fig. 1) . A/-Linked glycosylation in the mutant bLH/3-subunit at this site is highly unlikely, since the site-directed mutation was modeled upon the human homolog in which the presence of ile 15 of the mature hLH/3-subunit completely prevents A/-glycan addition at the nearby Asn 13 residue in vivo. Second, the pulse-chase analysis revealed essentially no turnover or secretion of radiolabeled NG-bLH/3-subunit over the course of the 22-h 8 Estimates of total a and total LH/3 were obtained at each time point of duplicate pulse-chase experiments by immunoprecipitation with anti-a and LH/3-sera, respectively, followed by autoradiography and densitometry. Dimer a-subunit represents the fraction of the total radiolabeled a-subunit that was immunoprecipitated with anti-LH/S-antiserum, while dimer LH/3 was obtained from immunoprecipitations performed with antia-subunit antiserum. b Half-time of secretion; represents the time at which half of the total LH subunit appears in the culture medium after the radioactive pulse (average of the two experiments), obtained by inspection from a linear plot of time vs. log (relative autoradiographic density of the a-and LH/3-subunit bands). c Levels of immunoprecipitable subunits were below detectable (B.D.) limits. chase (Fig. 2, Table 1 ), consistent with an increased intracellular concentration of the protein. This indicated a possible role of the A/-glycan in permitting the degradation of the LH/3-subunit, as fully glycosylated LH/3 displays a more rapid turnover rate of 6-8 h [Figs. 2C  and 3 (8, 11) ]. Third, newly synthesized NG-bLH/3 did not combine appreciably with a-subunit over the duration of the experiment, as demonstrated by the virtual absence of radiolabeled NG-bLH/3 in the «-antibody immunoprecipitations of MUT cell lysates and culture medium (Fig. 2, B and D) .
In contrast to the differences observed between wildtype and mutant LHj8, the kinetics of turnover and secretion of radiolabeled dimer «-subunit in the MUT cells were virtually identical to those observed in the WT cells (Fig. 2) . Radiolabeled dimer a-subunit was immunoprecipitated with LH/3-antiserum from MUT cell lysates as early as the 10-min pulse (Fig. 2D) , indicating the rapid combination of newly synthesized a-subunit with a preexisting pool of unlabeled NG-bLH/? subunit. Also, the appearance of radiolabeled dimer a subunit in the culture supernatants indicates that the a/(3 heterodimer is being secreted by the MUT cells (Fig. 2D) . The somewhat higher level of dimeric a subunit seen in the MUT cell culture medium at the 6-h chase time point is an artifact, as other pulse-chase experiments have failed to reproduce this observation. The overall rate of assembly of NG-bLH/3 is apparently unchanged relative to that of glycosylated LH/3 because the kinetics of secretion of dimer a-subunit in MUT cells is identical to that seen in the WT cells (Table 1) . Despite the increase in the intracellular concentration of NG-bLH/3 and the unaffected secretion kinetics of dimer a, newly synthesized (radiolabeled) NG-bLH/3 is not secreted within the 22-h chase period (Figs. 2, C and D, and 3; Table 1 ). Thus, as in the WT cells, newly synthesized «-subunit is combining with a preexisting population of assemblycompetent NG-bLH/3.
Hormonal Activity of bLH is Unaffected when NLinked Glycosylation of the /?-Subunit is Prevented
To study the role played by the single A/-glycan of the bLH/3-subunit in the hormonal activity of bLH, the wildtype and mutant forms of CHO-bLH were purified from culture supernatants and examined in a rat Leydig cell (MA-10) bioassay. Recovery of CHO-bLH from WT cells was assessed quantitatively over the course of purification by bLH ELISA (Table 2) , employing a preparation of CHO-bLH as the standard (P. Smith, D. Kaetzel, J. Nilson, J. Baenziger, submitted for publication), while the MA-10 cell bioassay was used to determine the efficiency of mutant CHO-bLH recovery (Table 3 ). The bLH ELISA was also used for rapid semi-quantitative screening of column fractions for the purification of both proteins. Q-Sepharose chromatography proved to be more efficaceous in the purification of wild-type CHObLH than the mutant protein (16-fold vs. 0.6-fold, respectively). The final Mono S step, while not a high recovery procedure, yielded nearly homogeneous preparations of both proteins. Wild-type CHO-bLH was essentially homogeneous as evaluated by SDS-PAGE and Coomassie blue (Fig. 4, top) or silver staining (data not shown), using conditions which retained heterodimer structure. The preparations contained only minor amounts of free LH/?-subunit. Mutant CHO-bLH was also highly purified by the procedure, containing only small amounts of unidentified protein species (Fig. 4,  top) . Wild-type CHO-bLH had an apparent mol wt of 33 k, consistent with a previous report (10) , while the mutant protein was slightly smaller in size (30 kDa), as predicted for a molecule lacking the LH/3-subunit Nglycan. The identity of these two proteins was confirmed by immunoblot analysis, which shows immunoreactive species of the expected sizes for wild-type and mutant CHO-bLH, as well as minor amounts of their respective free subunits (Fig. 4, bottom) .
The relative concentrations of wild-type and mutant CHO-bLH protein were determined by SDS-PAGE under conditions which retained heterodimer structure (Fig. 4, top, Refs. 10, 18 ). Included for comparison in the analysis was a preparation of bLH purified from bovine pituitary gland (courtesy of T. Nett, Colorado State University, Ft. Collins, CO). When equal masses of wild-type and mutant CHO-bLH were compared by immunoblot analysis, the reactivity of the anti-LH/3 antibody was approximately 5-fold stronger with wild-type CHO-bLH (Fig. 4, bottom) . ELISA analyses revealed a similar 5-fold difference in immunoreactivity between the purified preparations of wild-type and mutant CHObLH (data not shown). Collectively, these data indicate that prevention of AMinked glycosylation of the LH/3-subunit affected reactivity with the LH/3-antiserum used in these experiments. This unexpected change in immunoreactivity underscores the importance of using more direct methods for the measurement of protein mass, such as Coomassie blue staining of polyacryl- amide gels, to assess the effects of structural alterations on biological activity.
When examined in the MA-10 cell bioassay, which relies on the gonadotropin-stimulated release of progesterone (19) , no statistically significant differences were observed in the potency (ED 50 ), maximal stimulatory dose (Pmax), or dose-response curve slopes between wild-type and mutant CHO-bLH (Table 4 , Fig. 5 ). Repeated bioassays conducted with two different preparations of mutant CHO-bLH gave identical results. These results, obtained with rigorously quantitated preparations of wild-type and mutant proteins, clearly demonstrate that the single A/-glycan of the bLH/?-subunit does not play a significant role in the biological activity of bLH. Values within a column are not significantly different, P > 0.05. a ED 50 , the dose of bLH with an expected response half-way between the progesterone (P) output at zero dose (3.7 ng P/ ml) and the maximum stimulatory dose. b Pmax, The progesterone output at the maximum stimulatory dose. c Slope factor, calculated as described for the sigmoidal curvefitting paradigm described by DeLean ef al. (30) . 
DISCUSSION
Early studies involving chemical deglycosylation of purified glycoprotein hormone subunits and their individual subunits gave rise to the view that the A/-glycans of the a-subunit play a dominant role in signal transduction, but not for receptor binding (15) . More recent work, which employed oligonucleotide-directed mutagenesis to site-specifically disrupt AMinked glycosylation of the hCG subunits has generally supported this conclusion (14) . We have extended these studies on the role of Nlinked glycosylation for hCG signal transduction to the LH molecule, taking the additional step of purifying the wild-type and mutant forms of the protein to near homogeneity before bioassay. Purification of these proteins obviated any potential interference from contaminating molecules present in the crude culture supernatants of the WT and MUT cell lines. More importantly, purification permitted direct determination of the LH mass of the wild-type and mutant proteins, and therefore, determination of their hormonal potency by gonadotropin bioassay. Our observation that biological activity of the «:NG-bLHj3 heterodimer is unaffected by the absence of A/-glycan from its /3-subunit indicates that the carbohydrate plays a less dominant role in LH receptor binding and signal transduction than the «-subunit. This result is identical to that seen for the CG/3-subunit, despite the significant structural differences between these two proteins {i.e. amino acid sequence, the O-glycan rich carboxyl extension of CG/3) and suggests that the absence of a role for A/-linked glycosylation in signal transduction may be a general feature of all glycoprotein hormone /3-subunits.
In marked contrast with the lack of effect on biological activity, our studies have indicated an important role of AMinked glycosylation for the intracellular stability, assembly, and secretion of the bLH/3-subunit. Prevention of AMinked glycosylation of the LH/3-subunit by site directed mutagenesis causes its accumulation inside the cell, due in large part to an increased stability of the protein (t 1/2 of turnover > 22 h). Fully glycosylated LH/3-subunit is also remarkably stable inside the cell when expressed in the absence of a-subunit, but displays an intracellular half-time (~8 h) which is significantly lower than that of NG-bLH/3 (8) . When uncombined, fully glycosylated LH/3 is sensitive to endoglycosidase H, consistent with its retention in a pre-Golgi compartment (ER) before assembly (11) . Therefore, the ER is also the most likely site of intracellular accumulation of NGbLH/3. It should also be noted that removal of A/-glycan did not permit release of radiolabeled NG-bLH/3 from the cell, indicating that the oligosaccharide does not provide a signal for ER retention of LH/3.
Corless et a/., (11) have proposed that delayed secretion of LH/3-subunit is the result of its selective sequestration within the ER, and that only upon combination with a:-subunit can the LH/3 subunit be secreted by the cell. This is reminiscent of the rescue of immunoglobulin heavy chains from the ER through binding to light chains (20) . In support of this hypothesis, we have also observed that free LH/3 is not secreted in detectable quantities from CHO cells which produce the bLH dimer (10) . The observation that newly synthesized LH/3-subunit is not immediately available for combination after its synthesis indicates that the protein may require some form of processing before it is available for combination and secretion. Furthermore, the long intracellular t 1/2 (>22 h) for NG-bLH/3 is consistent with its accumulation in the ER, analogous to the transport arrest observed for non-glycosylated influenza virus hemagluttinin (21) .
Our results obtained with the single A/-glycan of bLH show some similarities as well as differences with recent studies on the role of the two A/-glycans of the hCG/3-subunit (13) . Nonglycosylated /3-subunits from both bLH and hCG have longer intracellular half-lives, and exhibit delayed secretion kinetics relative to their glycosylated counterparts. Another similar finding is that the assembly and secretion kinetics of newly synthesized a-subunit remain unaffected by the delayed degradation and secretion of the nonglycosylated /3-subunits. A difference between the bLH/3-and hCG/3-subunits, however, is that disruption of the single Nlinked glycosylation site (Asn 13 ) of bLH/3 markedly increased intracellular stability and delayed secretion. These effects were not observed when the analogous site in the hCG/3-subunit (Asn 13 ) was site specifically mutated, and occurred only when both A/-linked glycosylation sites were simultaneously disrupted. Taken together, these results suggest that at least one Nglycan is required for the normal kinetics of degradation and secretion of these two similar glycoprotein hormone subunits.
The lag period during which LH/3-subunit (both wildtype and NG-bLH/3) is not available for combination is consistent with a time-dependent conversion from an assembly-incompetent state to an assembly-competent state, and therefore, the coexistence of intracellular pools of these LH/3-forms. In this regard, Ruddon ef a/. (22) have described a short-lived {t 1/2 = 4 min), assembly-incompetent precursor of the hCG/3-subunit which, through the formation of intramolecular disulfide bonds, rapidly acquires an assembly-competent conformation.
How can we explain the apparent inconsistency in our observations of rapid heterodimer assembly of newly synthesized a-subunit, but nonexistent assembly of newly synthesized (radioactive) NG-bLH/3 over the 22-h pulse-chase? It is unlikely that this is due to inefficient combination of NG-bLH/3 with a-subunit because the secretion kinetics of newly synthesized dimeric a-subunit (that which precipitates with LH/3-antibody; Fig. 2, C and D and Fig, 3, A and B) are identical in cells expressing the wild-type or mutant form of LH/3. Moreover, because the secretion kinetics of dimeric aare identical, a large pool of unlabeled (previously synthesized) LH/3 must be available for combination. Thus, one possible explanation for lack of a dimeric form of radioactive NG-LH/3 is that the pool of NG-LH/3 is much larger than that of wild-type LH/3; this could lead to isotopic dilution and reduction of specific activity to the extent that newly synthesized LH/3 is undetectable. This possibility is consistent with the increased intracellular half-life of NG-LH/3. Another explanation for the lack of radioactive dimeric NG-LH/3 is that the absence of an A/-glycan increases the transit time required for conversion of LH0 from an assembly-incompetent to an assembly-competent form. If the flow of LH0 from one pool to the next is unidirectional, then the time required for moving a pulse of radiolabeled LH/3 through the two pools would likewise be increased. For example, Nglycan addition may facilitate proper folding of LH/3 which in turn could represent the rate-limiting step in formation of assembly-competent LH/3. In support of this hypothesis, nonglycosylated a-subunit (obtained from either cell-free translation or recombinant bacteria) has been shown to fold in vitro into an assembly competent form in very low yield as compared to the fully glycosylated protein [3% vs. 100%, respectively, after 48 h; (23)]. Also, nonglycosylated LH/3-subunit obtained by cell-free translation is incapable of combining with native a-subunit in vitro. Finally, neither of the above possibilities are mutually exclusive. Thus, failure to detect radioactive, dimeric NG-LH/3 during the 22-h pulsechase experiment may be due to a combination of both events.
Recently, pools of assembly-competent and assembly-incompetent hCG/3 subunit have been identified by SDS-PAGE under nonreducing conditions (22) , presumably as a result of distinct patterns of intrasubunit disulfide bonding for these two forms of the protein. A similar approach may be possible in the measurement of transition rates between assembly-incompetent and assembly-competent pools of the LH/3 subunit. The WT and MUT cell lines should prove to be useful in such future studies directed to understanding the critical events involved in the biosynthesis of assembly-competent LH/3-subunit.
MATERIALS AND METHODS
Site-Directed Mutagenesis of the LH/? Subunit Gene
Disruption of the signal for A/-linked glycosylation of the bLH/3-subunit gene was accomplished by site-directed mutagenesis of single-stranded M13 DNA template by the protocol of Zoller and Smith (24) . The DNA template included a 1.8 kilobase (kb) genomic Pst\ restriction fragment that encompassed all of the exons, as well as some 5'-and 3'-flanking sequence, of the bovine LH0 subunit gene (16, 25) .
Isolation of LH-Producing CHO Cell Lines
A methotrexate-selected CHO cell line [LH«1-1 /*M (10)] which expressed bovine a-subunit protein at high levels was transfected with the expression vectors encoding either wild-type or mutant LH^-subunit, using the Polybrene method (26) . These vectors were cotransfected with the selectable marker plasmid pSV2neo (10 ^g pRSVbLH/3: 2 ng pSV2neo) to obtain stable transformants by selection with G418. Surviving clones were individually transferred to 24-well plastic dishes (15 mm) and culture supernatants were assayed for the presence of immunoreactive bLH/3 by a double antibody-sandwich ELISA (27) . Wells of a 96-well microtiter plate were coated with equine anti-bLH serum (courtesy of T. Nett), then incubated sequentially with either purified bLH/3 or culture supernatants, rabbit anti-bLH/3 serum (antigen and rabbit antibody courtesy of J. Pierce, UCLA, Los Angeles, CA), goat anti-rabbit immunoglobulin (lgG)/alkaline phosphatase conjugate, and the chromogenic substrate p-nitrophenyl phosphate. Two positive wildtype and 20 positive mutant LH/3-clones were isolated and progressively expanded in 60-and 100-mm plastic dishes. (10) , and chased with excess unlabeled methionine (100-fold molar excess) for the indicated times. Cell lysates were prepared in ice-cold buffer (10 mM Tris HCI, 66 mM Na 2 EDTA, 0.4% Na deoxycholate, 1% Nonidet P-40, and 0.5 mM phenylmethylsulfonyl fluoride, pH 7.5,1 ml/ plate). Preparations and immunoprecipitation of samples, SDS-PAGE, and autoradiography (1-week exposure) were performed as described previously (10, 16).
Purification of LH from WT and MUT Cells
WT and MUT cells were plated on plastic 100-mm dishes at high density for collection of crude culture supernatants containing secreted LH (4 x 10 6 cells per dish, 200-400 dishes per collection). After maintenance for 24 h in serum-containing culture medium (Dulbecco's modified Eagle's medium, 5% fetal bovine serum, 10 mM nonessential amino acids, 2 mM glutamine, 50 U/ml penicillin, 50 /j.g/vr\\ streptomycin, and 1 /UM methotrexate), the cells were washed extensively with Dulbecco's PBS ( 3 x 4 ml/plate), switched to fresh culture medium (same as above, but serum-free), and maintained for 4 days. Unless otherwise noted, all subsequent manipulations were performed at 4 C or less. Culture supernatants were harvested and subjected to ammonium sulfate precipitation (33-50% saturation). Protein pellets were stored at -8 0 C, until further purification. Protein pellets were resuspended in 10 ml buffer A (25 mM Tris, 100 mM NaCI, pH 9.0) and extensively dialyzed ( 3 x 1 liter) against the same buffer to remove residual ammonium sulfate. The dialysate was then applied to a column of Q-Sepharose anion exchange resin (18 x 1.6 cm, Pharmacia, Piscataway, NJ), preequilibrated in buffer A, using an FPLC solvent delivery system (1 ml/min) and UV monitor. Fivemilliliter fractions were collected, with most immunoreactive LH eluting in the pass-through fractions (7) (8) (9) (10) (11) (12) . The column was regenerated by a wash with buffer B (25 mM Tris, 1 M NaCI, pH 7.0). The pass-through fractions were pooled, dialyzed against buffer C (50 mM sodium phosphate, pH 7.4), and applied directly to a column of Mono S (cation exchange, 0.5 x 5 cm). LH was shown to bind to the resin under these pH and salt conditions, and was the major protein species to be eluted with a 50 ml NaCI gradient (buffer C, 0-1 M NaCI). LH eluted in the first 10 ml NaCI gradient, and was followed over the course of the next 8 ml by other minor contaminants (data not shown). The LH-containing fractions (verified by ELISA and SDS-PAGE/silver stain, see below) were pooled, dialyzed into 1 % ammonium bicarbonate buffer, and concentrated by lyophilization.
Assessment of Quantity and Purity of LH Preparations
Total protein in unfractionated and fractionated samples was quantified by the method of Lowry et al. (28) , using sodium deoxycholate and trichloroacetic acid precipitation. Using a purified CHO-bLH preparation as a standard, 1 LH recovery was quantified over the course of purifications by the rat Leydig cell (MA-10) bioassay. The MA-10 cell line is very sensitive to gonadotropin stimulation, producing a number of sex steroids (19) ; of these, progesterone is predominant and conveniently measured by RIA. In the purification of wild-type CHO-bLH, ELISA was also employed to assess recovery. The purified proteins were subjected to SDS-PAGE under low temperature, nonreducing conditions which have been demonstrated to maintain heterodimer stability (10, 18) . The proteins were visualized by Coomassie blue and silver staining (29) , and by immunoblot procedures; the latter was performed essentially as described (10) , using the polyclonal rabbit antibovine LH/3 and goat anti-rabbit IgG-alkaline phosphatase conjugate antibodies that were employed in the LH ELISA.
The preparation of CHO-bLH obtained from the WT cells was indistinguishable from the CHO-bLH standard in both its immunoreactive and hormonal properties, and was essentially homogeneous when evaluated by SDS-PAGE and silver stain. The mass of purified mutant CHO-bLH was quantified by SDS-PAGE and densitometry of Coomassie blue-stained gels, using the fully glycosylated CHO-bLH preparation described above as the standard. Based on the mass determination, ELISA analysis of purified wild-type and mutant preparations revealed a 5-fold lower immunoreactivity for the mutant protein. Therefore, comparisons of the biological activities of these proteins were based upon their relative mass and not by immunoreactivity.
Assessment of hormonal activity was performed in the MA-10 cell bioassay by generating dose-response curves with increasing amounts of the purified wild-type and mutant proteins. Results obtained for each CHO-bLH preparation were confirmed by two independent bioassays. Statistical analysis of bioassay dose-response curves was performed with the computerized dose-response algorithm, ALLFIT (30) .
